Microcystins (MCs) are cyanobacterial toxins which place the public at risk via exposure to MC contam inated water, food or algal food supplements. Subsequent to the fatal intravenous exposure of dialysis patients in Caruaru, Brazil, several techniques (LC MS, GC MS and ELISA) were adapted to detect MCs in human serum. As patients chronically exposed to low concentrations of MCs also present with very low MC serum levels, only LC MS methodology would appear to allow detection of these MC levels. How ever, LC MS detection depends on the availability of respective MC congener standards and the levels of non covalently bound MC in the sample. In contrast, immunological techniques, e.g. MC ELISA poten tially could detect even covalently bound MC, provided the MC antibody was raised against an epitope found in nearly all of the MC congeners. As the Adda side chain moiety is present in nearly all of the MC congeners known to date, the anti Adda antibodies, when applied in Adda ELISAs, could represent a relatively simple and robust technique for the qualitative and quantitative determination of MC in human serum.
Introduction
Microcystins (MCs) are toxic cyclic hepta peptides produced by certain cyanobacteria, predominantly by the cyanobacterial genera Anabaena, Microcystis, Nostoc and Planktothrix [1] . Toxic algae blooms are a problem worldwide found in all types of water bodies, they appear to increase in frequency with climate change associated higher average annual ambient temperatures. Although many countries in the Western world introduced monitoring strategies, developing countries especially face increasingly harmful algal blooms due to intensified agriculture and industry, which pose a significant threat to public health [2] .
More than 80 MC congeners have been identified to date [3] , whereby MC LR is the best characterized congener and is also clas sified as a 2B carcinogen by the International Agency for Research on Cancer (IARC) [4] . As cyanobacteria are able to produce different MC congeners simultaneously, affected waters are always contami nated with a whole range of different MCs [5] . This was shown for example for the cyanobacterium Microcystis aeruginosa PCC 7820, where MC LR, LY, LW and LF were detected [6] . Concomitant with the structural differences the toxicity of the congeners vary, whereby a priori the toxicity appears to be governed more by kinetic rather than dynamic differences amongst congeners [7, 8] . While the kinetics of MC uptake appears primarily dependent on trans mem brane transport by organic anion transporting peptides (OATPs) [9] , the toxicodynamics are characterized by a highly specific inhibition of ser/thr protein phosphatases (PPs) [10 12] . Corresponding with a first pass effect and a high expression of OATPs and PPs, the imme diate result of acute exposure to MCs of humans and other mamma lians is liver damage followed by a hepatic renal syndrome and multi organ failure, as exemplified by dialysis patients in Caruaru, Brazil, in 1996 [13] . The latter patients were exposed to MCs in dial ysis centers with dialysis water contaminated with MCs.
Following the severe morbidity and ensuing mortality of patients, sera from these patients were analyzed repeatedly for the presence of MCs by various investigators [14 17 ]. The analyses included several detection methods such as ELISA, LC MS and GC MS as well as diverse sample preparation methods. While one group of investigators found MC serum concentrations ranging from 60. 16 to 0.96 lg/L [17] , others detected a mean serum concentration of 2.2 lg/L [18] . Single values were as high as 133 lg/L [15] . The pre dominant congeners in the patient serum detected were MC LR, YR, and AR [19] . To date, most of the available data on the detection of MCs in human serum is associated with the Caruaru event.
Additionally, a second, less severe MC exposure during hemod ialysis occurred in Rio de Janeiro, Brazil, in 2001. From this event, affected patients were screened amongst other things for MC in serum [20] . Thirteen out of 44 patients showed detectable MC lev els with a maximum median level of 0.61 lg/L [20] .
Beyond the accidental intravenous exposure with the associated acute effects, there are more common routes of human exposure to MCs. These include the ''voluntary'' uptake of MC contaminated algal food supplements, consumption of contaminated food (e.g. fish and crayfish from water bodies with known frequent occur rences of algal blooms or vegetables and salads watered with con taminated water) [21, 22] , as well as MC exposure via contaminated drinking water, thereby leading to chronic MC exposure. Indeed, MCs and other toxins are frequently detected in algal food supple ments, ranging from approximately 0.1 5.7 lg MC LR eq per gram dry weight [22, 23] .
To date, only very limited data are available on human contami nation levels following exposure to contaminated drinking water, food or food supplements. For example, Chen and co workers inves tigated fishermen at Lake Chaohu, China, chronically exposed to MCs via drinking water, aerosols and consumption of aquatic food. MCs were detected in serum samples at an average of 0.39 lg MC LR eq /L [24] . Similarly, Li and co workers analyzed samples from children exposed to contaminated drinking water and aquatic food and found serum concentrations ranging from 0.4 to 1.3 lg MC LR eq /L [25] .
In light of the 2B human carcinogen classification of MC LR by the IARC [4] and in view of the recent suggestion that MC mediated neurotoxicity could predispose for human neurodegenerative dis eases [7, 8] , any exposure with MCs must be regarded as potentially harmful to humans. Thus the routine robust and sensitive detec tion of low levels of microcystins in human blood serum will be the key to identifying patients potentially at high risk for diseases associated with chronic MC exposure. ELISA based methods have been proven to be suitable tools for the detection of MCs in water, in cyanobacterial cells and in exposed human, animal and plant materials, although some methodological constraints and require ments are essential for the outcome [26] . Consequently, this study aimed to evaluate two different commercially available ELISAs, with their respective sample preparation methods, with respect to their applicability for the reliable detection of MC LR, YR, RR, LA, LW, LF as well as defined MC mixtures in human blood. In addition, the suitability of these methods for the detection of MCs in in vitro applications was tested using bovine serum (FBS), which is a typical ingredient in cell culture media, and a complete standard cell culture medium containing 10% FBS. 
Materials and methods

Materials
Sample extraction for the detection in the Adda ELISA
The extraction procedure is summarized in Fig. 1 .
Purification of toxins from extracts via SPE for the detection via the Adda ELISA
Solid phase extraction (SPE) was performed using Oasis HLB 6 cc (200 mg) cartridges, according to the manufacturer's instructions (Waters GmbH, Eschborn, Germany), in order to purify and concen trate toxins in the extracts (Fig. 1) . Briefly, SPE columns were precon ditioned with 100% MeOH (2 ml) and equilibrated with deionized water (2 ml). Extracts were applied to the columns and the columns then washed with 30% (v/v) MeOH in 0.1 M acetic acid (3 Â 2 ml). 80% MeOH (5 ml) was employed for MC elution from the column. Collected eluates from the same sample were combined and evapo rated to dryness under a stream of nitrogen. Dried samples were resuspended in 500 ll 5% (v/v) aqueous MeOH, vigorously mixed and sonicated for 5 min. The final samples were stored at À20°C until further use.
Adda ELISA
Extracts, prepared via methanol extraction and SPE, were ana lyzed using a commercially available Adda ELISA kit (''Microcys tins/Nodularins (ADDA) ELISA'', Abraxis LLC, Warminster, PA, USA; cat# 520011) according to manufacturer's instructions. This indirect competitive ELISA recognizes specifically the Adda moiety present in all known MC congeners via a polyclonal antibody [30] , thus detecting MCs independent of the congener. All samples were ana lyzed in triplicate on each plate and three independent samples were generated for all analyses. Before use in ELISA samples were diluted to fit the linear range of the assay (0.15 5 lg/L), with all sam ples above 1 lg/L being diluted to nominally 1 lg/L. The resulting MC concentrations were calculated from the MC LR standard cali bration curve and are presented as MC LR equivalents (MC LR eq ). Samples, which were out of the range of the standard curve of each ELISA, were considered to be below the limit of detection (<LOD). The test sensitivity and reproducibility was given by the manufac turer with limit of detection (LOD) of 0.1 lg MC LR/L and coeffi cients of variation (CVs) of <10% and <15% for standards and samples, respectively. No information was available with regard to the recovery of MCs, however a theoretical range of recovery of 80 120% was set based on own preliminary data and detected CVs and other observations from the manufacturer and other investiga tors [30, 31] .
Sample preparation for the detection of MCs with the Serum ELISA kit
Serum samples were extracted and analyzed using a commer cially available Microcystin ELISA kit for serum (Abraxis LLC, War minster, PA, USA; cat# 522031) according to manufacturer's instructions (Fig. 1 ). This direct competitive ELISA recognizes specifically the Adda moiety present in all known MC congeners via a monoclonal antibody [32] , thus detecting MCs independent of the congener. All samples were diluted to nominally 0.5 lg/L to fit into the standard calibration range of this direct competitive Serum ELISA (0.1 1.0 lg MC LR/L), the resulting MC concentra tions were calculated from the MC LR standard calibration curve and are presented as MC LR eq . Samples, which were out of the range of the standard curve of each ELISA, were considered to be below the limit of detection (<LOD). The test sensitivity and reproducibil ity was given by the manufacturer with an LOD of 0.40 lg MC LR/L and CVs of 10% and <15% for standards and samples, respectively. The sample recovery from human serum was indicated as being 70 130%.
Samples for the comparison of different storage vessels
MC LR, LW or LF were spiked into ELISA diluent at 1 lg/L in glass vials and were then transferred into different vessels: polypro pylene microcentrifuge tubes (PP (E), very slightly opaque, Eppen dorf, cat# 022363352), polypropylene microcentrifuge tubes (PP (T), clear, Thomas Scientific, cat# 1232G82), polypropylene micro centrifuge tubes (PP (V), clear, VWR, cat# 20170 355), low density polyethylene (LDPE) bottles (Wheaton, cat# W242831 A), high density polyethylene (HDPE) bottles (Nalgene, cat# 0331325A), and glass vials with Teflon lined caps (La Pha Pack, cat# 13090222). These samples were stored at 4°C and tested after 24 h and 48 h using the monoclonal based ELISA as described above. For each vessel type, one aliquot was analyzed with no mixing whereas the other aliquot was analyzed with mixing prior to pipet ting onto the microtiter plate.
Samples for inter laboratory comparison
Three types of spiked samples were analyzed in each of the two laboratories: (1) samples using the lab's own serum lot and the own MC stock solutions, (2) samples using the lab's own serum lot and the MC stock solutions of the other lab and (3) samples completely prepared by the other lab. These samples were pro duced using MC LR, LW and LF and 10 lg/L and 100 lg/L.
Calculations and statistical data analysis
ELISA data were processed according to manufacturer's instruc tions. Briefly, absorbance values were calculated as percentage of negative control for each plate and compared with the calibration data achieved via linear regression analysis. If appropriate, means ± SDs were calculated from at least three independent sam ples conducted in triplicate. These recovery data were then com pared by One way ANOVA with Dunnett's Multiple Comparison Test to a theoretical recovery range of 80 120% and 70 130% for the Adda ELISA and the Serum ELISA, respectively. Data are pre sented as means ± SEM. Significant differences are indicated as fol lows: p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). All statistical analyses were performed using GraphPad Prism 5.03 software. In case of results from single experiments, data is presented without any further calculations or statistical analysis. Fig. 2 summarizes the recovery data for MC LR using both ELISAs and the respective sample preparations (Fig. 1) . A good recovery (approximately 80 120%) and reproducibility was achieved with MC LR concentrations ranging between 1 and 100 lg/L using the polyclonal Adda ELISA (Fig. 2A) . These values were in accordance were recovered, however all results overestimated the true concen tration by approximately 60 80% (Fig. 2B ). Additional testing with MC LR up to 1000 lg/L showed similar results for both ELISAs (data not shown).
Results
Recovery of MC LR from spiked human serum in both ELISAs
3.2. Recovery of MC LR from spiked bovine serum and cell culture medium using the Serum ELISA Using the monoclonal Serum ELISA, specifically designed for human serum, the same recovery experiment described above was performed using fetal bovine serum (FBS) (Fig. 3A) and a typ ical cell culture medium (DMEM) supplemented with 10% FBS (Fig. 3B) . Again, the results overestimated the true concentrations. This effect was higher with higher FBS content of the sample matrix suggesting that undiluted bovine serum may produce increased matrix effects in the monoclonal Serum ELISA.
Recovery of six MC congeners from spiked human serum in both ELISAs
Six MC congeners (MC LR, YR, RR, LA, LW and LF) and an equimolar mixture of all six congeners were tested using both ELI SAs after application of the respective sample preparation method (Fig. 1) . Here, three different concentration levels were chosen (1, 10 and 100 lg/L). With both ELISAs differences were observed between the concentrations and the congeners (Fig. 4) . In the poly clonal based Adda ELISA, MC LR, YR, RR as well as the mixture showed good recoveries, whereas for MC LA, LW and LF signifi cant lower recoveries were observed (Fig. 4A) . Furthermore, the recovery increased with increasing concentrations.
In the monoclonal Serum ELISA, all congeners as well as the mixture were reproducibly recovered, however for MC LR, YR, RR and the mixture the true values were rather overestimated (Fig. 4B) . Overall little differences in recovery were observable between the two concentrations of MC congeners tested (10 and 100 lg/L).
Inter laboratory comparison and storage vessel effects on recovery
The initial comparison of the results obtained by the two labo ratories involved in this study demonstrated decisive differences in the recovery and precision of both ELISAs used. The latter differ ences were most prominent for MC LW and MC LF (data not shown). Therefore, a more profound inter laboratory comparison was performed using MC LR, LW and LF and the monoclonal based Serum ELISA in order to identify and eliminate the responsi ble parameter(s) for the differential outcome. The three main parameters that needed to be adapted were the methanol concen tration, type of sample container used, and the preparation of MC stocks (Table 1) . Specifically the type of sample container used for the final dilutions prior to the ELISA had a major effect on the outcome and was analyzed with more detail. Fig. 5 shows the effect of different standard vessels on the recovery of MCs after short term storage for the selected three MC congeners with and without vortexing. For MC LR, a ranking could be established: glass > HDPE > LDPE > PP (Fig. 5A) . For PP the specific composition as represented here by the different suppliers appeared to be crucial. The material ranking was found to be the same for MC LW and MC LF, however the overall recovery observed was MC LR > MC LW > MC LF with all vessel types except those made of glass ( Fig. 5B and C) . Furthermore, mixing of the samples prior to pipetting resulted in higher recoveries of all three congeners from almost all vessel types. Longer contact of MC congeners to the stor age container generally resulted in higher loss of MC congeners from the solutions.
Subsequent to agreeing to a common procedure (Table 1 ) the ELISA analyses provided for similar results in both laboratories (Fig. 6) 
Discussion
Toxic cyanobacterial blooms and the associated human expo sure require close monitoring in order to minimize the potential human health risks, especially in regions where water treatment for the preparation of drinking water is not as well established as it is in the more developed countries of Western Europe, North American, Australia and New Zealand. A prominent example is Lake Atitlan in Guatemala, where the first significant cyanobacte rial bloom occurred in 2008 and thereafter the blooms were increasingly serious with disastrous effects for the country [33, 34] . In Uruguay, the Rio Uruguay and La Plata River estuarine 
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. system, which is the fifth largest in the world, is similarly affected (33, 35) . For this system a program was initiated to exploit the potential of ELISAs to provide a low cost environmental analysis. This assay indeed enabled the first systematic monitoring of water from the Rio de la Plata at Montevideo and has been finally inte grated into a bi national effort to monitor the Rio de Ia Plata (36) . Similarly, an ELISA based monitoring system could be useful for the assessment of exposed inhabitants of toxic cyanobacterial bloom affected regions. Both parameters, MCs in the water and in the serum of exposed inhabitants would allow better assess ment of potential toxin uptake as well as provide for a basis to epi demiologically investigate the co occurrence of high inddences of diseases that could be assodated with MC exposure. Known quantitative detection methods for MCs indude the pro tein phosphatase inhibition assay (PPlA), HPLC. LC MS and ELISA with the respective different levels of sensitivity and robustness (26.37 39). The PPlA is very sensitive (LOD-O.Dl 03 11g/L) but prone to inhibitory matrix effects (37, 38, 40) . HPLC approaches are less sensitive with typical detection limits of 0.5 1 11g/l (37,38~ LC MS is very sensitive (LOD 0.02 0.5 ~/l) and highly specific, but requires expensive equipment and highly skilled per sonnet (6,37.38) . Both HPLC and LC MS largely depend on the availability of certified MC standards that then allow quantifying individual MC congeners. In contrast, EliSAs are generally highly sensitive (LOD-0.02 0.15 ~tg/L), fairly robust to matrix effects [26, 37) and do not require certified standards of individual MC congeners. With respect to sensitivity and selectivity, a ranking of EUSA > LC MS 5 HPLC was determined, whereas for costs, time and training required the ranking is reversed, i.e. LC MS > HPLC > EUSA (38(. Irrespective of selectivity and sensitivity, there is no single method available that is capable of detecting, lest quantifying, all potential MCs present in a given sample for reasons induding lack of standards, limited sensitivity of detection for a given MC congener, and limitations in quantification due to loss during extraction or matrix effects etc. One of the potential solu tions in LC MS analyses, at least for the latter issue, is the use of stable isotope labeled MC congeners as internal standards and extraction tracers. Indeed, spiking analytical samples with a stable MC isotope prior to extraction allows to correct for sample loss during preparation and ion suppression during analysis (39(. How ever, in absence of commercially available stable isotope labeled MC congener, other internal standards. such as thiol MC lR can be employed in HPLC and lC MS detection 116), albeit with the restrictions that thiol MC lR behaves differently during organic sample extraction than the parent MC LR.
Another important challenge that would allow m uch broader implementation of MC detection across the world is making MC analyses faster, cheaper, and more robust. making it feasible for IS regions without highly skilled personnel and sophisticated and expensive equipment. The EUSAs used in the study here represent such a method. The monoclonal based Serum ELISA is an espe cially fast and comfortable approach. Sample preparation is achieved within 30 min (compared to 2 3 days in the Adda ELISA). highly convenient (kit based) and needs only low cost equipment (microcentrifuge and plate reader).
In the study here, both chosen EUSAs in combination with their corresponding extraction procedures were able to detect MC lR in human serum, but with different recoveries. MC lR recovery was within the expected recovery range for all concentrations tested in the polyclonal Adda EUSA. whereas all concentrations were generally overestimated using the monoclonal Serum ELISA A similar picture was obtained when using six different MC congen ers(i.e.MC LR, YR. RR, LA, LWand LF)andequimolarmixtures thereof. Of these congeners, MC LR. YR and RR were detected with reasonable recoveries in the polydonal Adda ELISA while recoveries were overestimated in the monoclonal Serum EUSA. when compared to the expected recovery ranges. MC LA, LW and LF were underestimated using the polyclonal Adda EUSA, whereas they were detected correctly using the monodonal Serum ELISA, although the latter may represent a compensatory effect of general overestimation and lower recovery. Furthermore. the congeners were used as single toxins and as defined mixtures, resulting in a comparable detection of the congeners in the mixture compared to the single detection, indicating an equal or at least similar recognition of the chosen congeners by the antibody, which corroborates earlier data (30) . The observed d ifferential recoveries of the different MCs are therefore not due to a differential recogni tion by the antibodies but rather due to a different behavior during the extract ion procedure. This assumption is supported by the cur rent preliminary data on the effects of storage vessels and is con firmed by very recent data from our laboratory (41 ) .
In summary, from the current data it can be concluded that both EUSAs are suitable for MC analysis in human serum. Although the correct quantification depends on the congeners present in a serum analyte. the EUSAs are at least suitable tools for a prelimin ary screening of samples. The recoveries obtained in the current study are in good accordance with data from other studies using similar techniques. For example an ELISA utilizing anti MC poly clonal serum showed similar cross reactivity of MC congeners (MC RR, 68%; MC YR. 68%, MC LW, 52%, MC LF, 77%) (33 ).
Additional testing was performed with the serum ELISA in order to determine its suitability for other applications. For this, the MC lR recovery experiment was repeated using bovine serum (FBS) instead of human serum Here, the results showed high deviations from the real concentrations indicating high matrix effects from the serum. These results are in accordance with similar observa tions using dog serum (Rubio, unpublished data). From these results it can be concluded that the serum ELISA is specifically use ful for the analysis of human serum but that it may not be suitable for sera from other species as matrix effects were high.
Moreover, t he suitability of the Serum EliSA for the detection of MCs in standard cell culture medium (DMEM containing 10% FBS) was investigated as this EUSA could serve to verify MC concentra tions employed in in vitro experiments. The MC concentrations commonly used in in vitro experimentations range from low nano molar to micromolar concentrations (e.g. up to 5 11M (42 )) and thus represent concentrations that are within the detection range of the EUSA However, based on the results obtained in the study here it must be concluded that the Serum EUSA is not suitable for this type of approach due to the high matrix related overestimation of the real MC concentrations.
In the human body, as well as in other exposed organisms induding plants and prokaryotes and protists. MCs are at least in part covalently bound to proteins, specifically serine/threonine phosphatases and therefore, extracts from biological samples may reflect only freely available MCs [11,12,43 45] . This was also shown for human serum as the analysis of serum samples from MC exposed kidney dialysis patients revealed that both free and bound MC forms were present [14] . Moreover, it was demon strated that the standard methanol extraction procedure is not suitable for extracting covalently bound MCs [12, 46] . In contrast, the data presented here reflect samples containing non covalently bound MCs only and thus do not represent the situation where both forms are present. Nevertheless, due to the type of interac tion, i.e. the covalent binding between the cystine residues of pro tein phosphatase 1 and 2 (PP) and the methyl dehydroalanine (Mdha) residue of the MCs [43 45] , it can be assumed that the anti Adda antibodies used in both ELISAs should be able to detect free as well as bound MCs as long as the sample preparation method would provide for both types of molecules. Indeed, the lat ter assumption is corroborated by the fact that the anti Adda anti body can be used in Western blots for detecting MC covalently bound to protein phosphatases 1 and 2 [3] .
Due to the detection range of the ELISAs, sample concentration and/or spiking may be required for detection of low levels of MCs in human serum. However, as the ELISA does not discriminate between MC congeners, yet MC congeners are subject to differential tissue/serum recoveries, only the addition of (a) stable isotope labeled internal MC standard(s) would allow more precise quantification, especially when coupled to subsequent LC MS analyses.
In conclusion, despite the research efforts of the past decades, further research is needed with respect to MC exposure, MC bio availability and subsequent toxicity in humans [2, 39] . For this, direct monitoring of human exposure levels and associated effects is prerequisite. In the study presented here, it was possible to dem onstrate that ELISA is an affordable, robust and sensitive method that could serve to fulfill the toxin monitoring requirements men tioned above.
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